Learning objective 1. Explain the pharmacologic, pharmacokinetic, and pharmacodynamic properties of vancomycin.
Learning objective 2. Determine a vancomycin loading dose for critically-ill patients with serious MRSA infections.
Learning objective 3. Given a patient with a suspected MRSA infection, recommend IDSA guideline-concordant empiric vancomycin maintenance dose and frequency.
Learning objective 4. Given a patient with a suspected MRSA infection, determine an empiric vancomycin maintenance dose and frequency based on population pharmacokinetics.
Learning objective 5. Given a patient with an MRSA infection, select an individualized vancomycin dose and frequency based on serum vancomycin level.
Learning objective 6. Given a patient on intermittent hemodialysis, recommend appropriate vancomycin dosing and monitoring.
Негізгі бет Pharmacokinetics-Pharmacodynamics of Vancomycin
Пікірлер: 4